NCT02806869View on ClinicalTrials.gov

Modernization of in vivo-in Vitro Oral Bioperformance Prediction and Assessment

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

July 31, 2017

Conditions
Human Gastrointestinal Physiology Data
Interventions
DRUG

Single dose of ibuprofen (800 mg tablet)

DIETARY_SUPPLEMENT

Pulmocare, two 8.0 oz (236.6 mL) cans

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

University of Michigan

OTHER

NCT02806869 - Modernization of in vivo-in Vitro Oral Bioperformance Prediction and Assessment | Biotech Hunter | Biotech Hunter